Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma

Cell division cycle associated 5 (CDCA5) has been associated with the progression of several types of cancers. However, its possible role and mechanism in hepatocellular carcinoma (HCC) remain unknown. In the present study, immunohistochemical staining and real-time PCR were used to assess CDCA5 pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianlin, Xia, Congcong, Pu, Meng, Dai, Bin, Yang, Xisheng, Shang, Runze, Yang, Zhen, Zhang, Ruohan, Tao, Kaishan, Dou, Kefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111608/
https://www.ncbi.nlm.nih.gov/pubmed/30015982
http://dx.doi.org/10.3892/or.2018.6579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111608/
https://www.ncbi.nlm.nih.gov/pubmed/30015982
http://dx.doi.org/10.3892/or.2018.6579

Ejemplares similares